Carol shared her latest research findings on the role of ANXA3 in mediating sorafenib resistance in HCC at the annual SKLLR Symposium held on Nov 11 2017. Stephanie also shared the team’s latest research work on PRMT6 in regulating liver cancer stemness and glucose metabolic rewiring.
The SMA Lab 